無料でクラウドストレージから最新のFast2test CCDS-O PDFダンプをダウンロードする：https://drive.google.com/open?id=1KaR3G8UAopiUUBpYv1iExCZseQMB98y-
早急にCCDS-O認定試験に出席し、特定の分野での仕事に適格であることを証明する証明書を取得する必要があります。 CCDS-O学習教材を購入すると、ほとんど問題なくテストに合格します。当社のCCDS-O学習教材は、高い合格率とヒット率を高めるため、テストにあまり合格しなくても心配する必要はありません。購入前に無料トライアルを提供しています。 CCDS-O練習エンジンのメリットと機能をさらに理解するには、製品の紹介を詳細にご覧ください。
| トピック | 出題範囲 |
|---|---|
| トピック 1 |
|
| トピック 2 |
|
| トピック 3 |
|
| トピック 4 |
|
| トピック 5 |
|
| トピック 6 |
|
Fast2testはウェブサイトだけでなく、候補者のための専門的な学習ツールとしても使用できます。 最後になりますが、CCDS-Oトレーニング資料の高度な運用システムを使用して、ACDISお客様に最速の配信速度を保証するだけでなく、お客様の個人情報を自動的に保護することもできます。 さらに、販売後の専門スタッフが、すべてのお客様に24時間年中無休でCCDS-O試験Certified Clinical Documentation Specialist-Outpatient問題に関するオンラインアフターサービスを提供します。 そして、CCDS-O学習ガイドの合格率は99％〜100％です。 CCDS-O練習準備で認定を取得します。
質問 # 49
A patient returns to a PCP for follow-up care related to a UTI. The provider documents "stage 3 CKD" as determined by a single eGFR of 52 mL/min. Which of the following actions should the CDI specialist take?
正解：D
解説：
The CDI specialist should review CKD staging criteria with the provider because assigning CKD based on a single eGFR value can be clinically unreliable and may lead to inaccurate documentation and coding. Outpatient CDI guidance emphasizes that documentation must reflect a condition that is clinically valid, supported by the record, and accurately described, especially for chronic diseases. CKD is generally established by evidence of decreased kidney function or kidney damage that is persistent, not a one-time lab that could be affected by hydration status, acute illness, medications, or transient physiologic changes. While an eGFR of 52 falls within the numeric range commonly associated with stage 3a, the key CDI issue is the foundation for diagnosing chronic disease, not simply whether the number is "reportable." Option A inappropriately directs CDI to add diagnoses to claims; CDI supports providers and coding, but does not independently "add" conditions. Option C is incorrect because chronic conditions may be coded when addressed/impact care, not only when actively treated. Option D is unsupported because eGFR 52 does not suggest stage 4.
質問 # 50
A patient is seen in the office for a persistent cough. Provider documentation states: "History of chronic obstructive pulmonary disease, asthma, and hypertension. Hypertension treated with Enalapril. Cough an adverse effect of the ACE inhibitor; discontinue Enalapril. COPD stable. Instructed to continue meds for COPD/asthma." Which of the following diagnoses should be reported for this encounter?
正解：A
解説：
Outpatient diagnosis reporting requires coding conditions that are evaluated, assessed, treated, or that influence care/management at the encounter. The chief reason for the visit is the persistent cough, which is assessed and attributed to an adverse effect of an ACE inhibitor (enalapril). For outpatient coding of medication adverse effects, the documentation supports reporting both the manifestation (cough) and the adverse effect of the drug (ACE inhibitor adverse effect), because the provider identified the causal relationship and changed therapy by discontinuing enalapril. In addition, the provider addresses chronic conditions that are clinically relevant to the visit: COPD is assessed as "stable" and the patient is instructed to continue COPD/asthma medications, demonstrating ongoing management. Hypertension also remains relevant because medication therapy is adjusted due to the adverse effect; the patient still has HTN even though one agent is discontinued. Therefore, all five items-cough, ACE inhibitor adverse effect, COPD, asthma, and hypertension-are supported and should be reported, making option D the most appropriate.
質問 # 51
The majority of E/M services are based on which of the following criteria?
正解：A
解説：
In outpatient CDI and coding education, selecting the correct E/M code starts with identifying the encounter category (e.g., office/outpatient vs inpatient/observation vs ED) and whether the patient is new or established, because these define the applicable CPT code range. Next, the level of service is selected within that range based on the documentation supporting the required elements for that code family. For most E/M services, "site of service" (place/setting) and "new vs established" are foundational code-selection drivers, while "level" is determined by the record's support for the applicable leveling methodology (commonly medical decision making and, when allowed/appropriate, time). Time can be a valid leveling method for many office/outpatient E/M visits, but it is not universally the basis for the majority of E/M services across all categories; it is an alternative pathway when documentation supports it. Physician specialty and patient age do not define the majority of E/M code selection. Therefore, the best overall statement is new/established status + site of service + level of service.
質問 # 52
Symbicort is used to treat which of the following conditions?
正解：D
解説：
Symbicort is an inhaled combination medication containing an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA). In outpatient chart review, this medication class is most strongly associated with chronic airway inflammatory diseases requiring controller therapy-especially persistent asthma (and also maintenance therapy for COPD, though COPD is not an option here). For CDI purposes, medication-to-diagnosis linkage can act as a clinical indicator supporting clarification when the visit note lists respiratory symptoms but does not clearly document the chronic condition being treated or its acuity/status. Symbicort is not used to treat musculoskeletal degenerative disease (osteoarthritis), peripheral nerve pain from diabetes (diabetic neuropathy), or cardiac pump failure (congestive heart failure). When Symbicort appears on the active med list, outpatient CDI commonly checks that the provider's documentation appropriately reflects asthma classification (intermittent vs persistent), current control, exacerbation status if applicable, and that the condition is being monitored/assessed/treated during the encounter to support reportability and accurate coding.
質問 # 53
Which of the following descriptors is classified as an uncertain diagnosis?
正解：D
解説：
In outpatient CDI and coding guidance, an "uncertain diagnosis" is identified by wording that indicates the provider has not confirmed the condition (e.g., possible, probable, suspected, rule out, question of, concern for). These terms reflect diagnostic consideration rather than an established diagnosis. Option A uses the phrase "concern for," which is a classic uncertainty qualifier and signals the provider is considering streptococcal pneumonia but has not definitively diagnosed it. In contrast, options B and D describe active treatment "for streptococcal pneumonia," which implies the provider is managing the condition as a working diagnosis; however, in outpatient coding, treatment alone does not automatically make a diagnosis confirmed if the documentation still reflects uncertainty-CDI would look for explicit provider confirmation. Option C ("evidence of") generally suggests supportive findings and is commonly interpreted as stronger than "concern for," though CDI would still assess whether the provider has clearly stated a confirmed diagnosis in the assessment/plan. Therefore, the clearest uncertain descriptor is "concern for."
質問 # 54
......
CCDS-O認定試験の準備をするために一生懸命勉強して疲れを感じるときには、他の人が何をしているかを知っていますか。あなたと同じIT認定試験を受験する周りの人を見てください。あなたが試験のために不安と感じているとき、どうして他の人が自信満々で、のんびり見ているのでしょうか。あなたの能力は彼らうより弱いですか。もちろんそんなことはないです。では、なぜ他の人が簡単にCCDS-O試験に合格することができるかを知りたいですか。それは彼らがFast2test のCCDS-O問題集を利用したからです。この問題集を勉強することだけで楽に試験に合格することができます。信じないのですか。不思議を思っていますか。では、急いで試してください。まず問題集のdemoを体験することができます。そうすれば、この問題集の品質を確認することができます。はやくFast2testのサイトをクリックしてください。
CCDS-O資格難易度: https://jp.fast2test.com/CCDS-O-premium-file.html
無料でクラウドストレージから最新のFast2test CCDS-O PDFダンプをダウンロードする：https://drive.google.com/open?id=1KaR3G8UAopiUUBpYv1iExCZseQMB98y-